HIV Infection: Drugs
(asked on 4th September 2019) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to widen access to the drug PrEP.
Pre-exposure prophylaxis (PrEP) is currently funded through the three-year PrEP Impact Trial. Following my Rt. hon. Friend the Secretary of State for Health and Social Care’s announcement on 30 January that the number of places on the trial would be doubled to 26,000, expansion of the Trial is now underway across the country. A core function of the PrEP Impact Trial Community Advisory Board (CAB) is to raise awareness and uptake of PrEP in key populations including black, Asian and minority ethnic (BAME) communities. Further information about PrEP Impact Trial CAB activities and participating community groups can be found at the following links:
https://www.prepimpacttrial.org.uk/faqs
In addition, Public Health England’s Innovation Fund has supported a number of community based projects aimed at increasing PrEP awareness in women, BAME groups and trans communities. Information on the projects funded in 2018 can be found at the following link:
https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018